COST-EFFECTIVENESS OF GASTRO-RESISTANT RISEDRONATE TABLETS FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN FRANCE

被引：0
|
作者：
Hiligsmann, M. [1 ]
Reginster, J. -Y. [2 ]
机构：
[1] Maastricht Univ, Maastricht, Netherlands
[2] Univ Liege, Liege, Belgium
来源：
OSTEOPOROSIS INTERNATIONAL | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OC34
引用
收藏
页码：S182 / S182
页数：1
相关论文
共 50 条
  • [31] Risedronate for prevention and treatment of osteoporosis in postmenopausal women
    Recker, RR
    Barger-Lux, J
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (03) : 465 - 477
  • [32] Cost-effectiveness analysis of screening for osteoporosis in postmenopausal Japanese women
    Nagata-Kobayashi, S
    Shimbo, T
    Fukui, T
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2002, 20 (06) : 350 - 357
  • [33] THE COST-EFFECTIVENESS OF ALTERNATIVE OSTEOPOROSIS SCREENING STRATEGIES FOR POSTMENOPAUSAL WOMEN
    Nayak, Smita
    Greenspan, Susan
    Roberts, Mark
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2010, 25 : 399 - 399
  • [34] Cost-effectiveness analysis of screening for osteoporosis in postmenopausal Japanese women
    Shizuko Nagata-Kobayashi
    Takuro Shimbo
    Tsuguya Fukui
    [J]. Journal of Bone and Mineral Metabolism, 2002, 20 : 350 - 357
  • [35] Cost-Effectiveness of Different Screening Strategies for Osteoporosis in Postmenopausal Women
    Nayak, Smita
    Roberts, Mark S.
    Greenspan, Susan L.
    [J]. ANNALS OF INTERNAL MEDICINE, 2011, 155 (11) : 751 - U176
  • [36] Cost-effectiveness of antiosteoporosis strategies for postmenopausal women with osteoporosis in China
    Li, Na
    Zheng, Bin
    Liu, Maobai
    Zhou, Haimei
    Zhao, Lingfen
    Cai, Hongfu
    Huang, Jingze
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2019, 26 (08): : 906 - 914
  • [37] Cost-effectiveness of romosozumab for the treatment of postmenopausal women with osteoporosis at high risk of fracture in Belgium
    Gielen, Evelien
    Aldven, Martina
    Kanis, John A.
    Borgstrom, Fredrik
    Senior, Emmanuelle
    Willems, Damon
    [J]. OSTEOPOROSIS INTERNATIONAL, 2024, 35 (07) : 1173 - 1183
  • [38] The effectiveness of alendronate, risedronate and calcitonin treatment in postmenopausal osteoporosis
    Yildirim, K
    Güreser, G
    Karatay, S
    Senel, K
    [J]. OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S121 - S121
  • [39] Cost-effectiveness of risedronate, alendronate and raloxifene in treatment of post-menopausal women with established osteoporosis in Germany
    Brecht, JG
    Kruse, HP
    Möhrke, W
    Oestreich, A
    Huppertz, E
    [J]. OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S59 - S59
  • [40] Ibandronate in the treatment of postmenopausal osteoporosis: A cost-effectiveness analysis in the UK
    Earnshaw, S.
    Lynch, N. O.
    Cowell, W.
    Beard, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 416 - 416
12345